Guangzhou Wondfo Biotech Co.,Ltd Share Price
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.77 CNY | -0.27% |
|
+4.11% | +10.23% |
| Capitalization | 10.11B 1.45B 1.24B 1.15B 1.08B 2.01B 133B 2.15B 13.23B 5.23B 62.87B 5.45B 5.33B 230B | P/E ratio 2025 * |
26.9x | P/E ratio 2026 * | 20.2x |
|---|---|---|---|---|---|
| Enterprise value | 10.11B 1.45B 1.24B 1.15B 1.08B 2.01B 133B 2.15B 13.23B 5.23B 62.87B 5.45B 5.33B 230B | EV / Sales 2025 * |
3.72x | EV / Sales 2026 * | 3.38x |
| Free-Float |
54.9% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -0.27% | ||
| 1 week | +4.11% | ||
| Current month | +10.23% | ||
| 1 month | +8.47% | ||
| 3 months | +2.40% | ||
| 6 months | -1.45% | ||
| Current year | +10.23% |
| 1 week | 20.91 |  | 22.9 |
| 1 month | 19.45 | | 22.9 |
| Current year | 19.75 | | 22.9 |
| 1 year | 19.26 | | 26.48 |
| 3 years | 19.2 | | 36.43 |
| 5 years | 19.2 | | 81.54 |
| 10 years | 16.17 | | 85.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhong Xiong Peng
CEO | Chief Executive Officer | 52 | 18/01/2023 |
Fang Xia Yu
DFI | Director of Finance/CFO | 49 | 10/04/2012 |
Jun Hua
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Mei Li
BRD | Director/Board Member | 63 | 31/12/1991 |
Ji Hua Wang
CHM | Chairman | 63 | 20/07/2016 |
Xiao Wei He
BRD | Director/Board Member | 67 | 10/04/2012 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +4.11% | -2.38% | -31.80% | 1.45B | |
| +0.77% | +6.58% | +156.48% | +265.14% | 14.91B | |
| -0.38% | -3.79% | -7.72% | +6.43% | 14.42B | |
| -3.01% | -3.56% | - | - | 7.19B | |
| -0.56% | -4.87% | -8.15% | +1.63% | 6.41B | |
| -0.03% | -2.70% | -29.90% | -41.34% | 4.64B | |
| +0.85% | +1.28% | -29.36% | +24.37% | 4.41B | |
| -0.19% | -1.34% | -8.18% | -43.73% | 3.02B | |
| +2.86% | +8.41% | +40.35% | -52.08% | 2.87B | |
| Average | +0.35% | +0.49% | +13.89% | +16.08% | 6.59B | |
| Weighted average by Cap. | +0.28% | +0.42% | +38.16% | +69.92% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.72B 391M 334M 310M 291M 540M 35.8B 578M 3.56B 1.41B 16.92B 1.47B 1.44B 61.8B | 3B 430M 368M 342M 320M 594M 39.41B 636M 3.92B 1.55B 18.63B 1.61B 1.58B 68.04B |
| Net income | 390M 55.96M 47.85M 44.41M 41.65M 77.28M 5.13B 82.75M 510M 202M 2.42B 210M 206M 8.85B | 515M 73.94M 63.21M 58.68M 55.03M 102M 6.77B 109M 673M 266M 3.2B 277M 272M 11.69B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/01/26 | 21.77 ¥ | -0.27% | 9,759,563 |
| 20/01/26 | 21.83 ¥ | -0.32% | 10,624,710 |
| 19/01/26 | 21.90 ¥ | -0.59% | 9,545,816 |
| 16/01/26 | 22.03 ¥ | +1.80% | 22,697,120 |
| 15/01/26 | 21.64 ¥ | +1.12% | 9,960,557 |
End-of-day quote Shenzhen S.E., January 20, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300482 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition